188 related articles for article (PubMed ID: 23979681)
21. Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
Sturm D; Pfister SM; Jones DTW
J Clin Oncol; 2017 Jul; 35(21):2370-2377. PubMed ID: 28640698
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region.
Ruge MI; Kickingereder P; Grau S; Dorn F; Galldiks N; Treuer H; Sturm V
Neuro Oncol; 2013 Dec; 15(12):1721-31. PubMed ID: 24046261
[TBL] [Abstract][Full Text] [Related]
23. Imaging characteristics of an unusual, high-grade angiocentric glioma: a case report and review of the literature.
Aguilar HN; Hung RW; Mehta V; Kotylak T
J Radiol Case Rep; 2012 Oct; 6(10):1-10. PubMed ID: 23378871
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.
Hickmann AK; Nadji-Ohl M; Hopf NJ
J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106
[TBL] [Abstract][Full Text] [Related]
25. Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.
Yang P; Wang Y; Peng X; You G; Zhang W; Yan W; Bao Z; Wang Y; Qiu X; Jiang T
J Neurooncol; 2013 Jun; 113(2):259-66. PubMed ID: 23483435
[TBL] [Abstract][Full Text] [Related]
26. Surgical management of incidentally discovered diffusely infiltrating low-grade glioma.
Opoku-Darko M; Lang ST; Artindale J; Cairncross JG; Sevick RJ; Kelly JJP
J Neurosurg; 2018 Jul; 129(1):19-26. PubMed ID: 28984519
[TBL] [Abstract][Full Text] [Related]
27. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
[TBL] [Abstract][Full Text] [Related]
28. Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.
Gömöri E; Pál J; Kovács B; Dóczi T
Diagn Pathol; 2012 Jan; 7():8. PubMed ID: 22264301
[TBL] [Abstract][Full Text] [Related]
29. A pregnant woman with recurring metastasis.
Chandra S; Pai SA; Venkataramana NK
Natl Med J India; 2001; 14(4):223. PubMed ID: 11547529
[No Abstract] [Full Text] [Related]
30. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
31. Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas.
Zeng J; Zhang XK; Chen HD; Zhong ZH; Wu QL; Lin SX
Oncotarget; 2016 Feb; 7(8):8944-55. PubMed ID: 26771840
[TBL] [Abstract][Full Text] [Related]
32. [The treatment of adult glioma is multiphasic].
Mäenpää HO
Duodecim; 2010; 126(14):1669-75. PubMed ID: 20804085
[TBL] [Abstract][Full Text] [Related]
33. Conservative management of presumed low-grade gliomas in the asymptomatic pediatric population.
Ali ZS; Lang SS; Sutton LN
World Neurosurg; 2014 Feb; 81(2):368-73. PubMed ID: 23321383
[TBL] [Abstract][Full Text] [Related]
34. Pulvinar Locus is Highly Relevant to Patients' Outcomes in Surgically Resected Thalamic Gliomas in Children.
Chiba K; Aihara Y; Masui K; Abe K; Komori T; Kawamata T
World Neurosurg; 2020 Feb; 134():e530-e539. PubMed ID: 31704359
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients.
Blonski M; Pallud J; Gozé C; Mandonnet E; Rigau V; Bauchet L; Fabbro M; Beauchesne P; Baron MH; Fontaine D; Peruzzi P; Darlix A; Duffau H; Taillandier L
J Neurooncol; 2013 Jun; 113(2):267-75. PubMed ID: 23479036
[TBL] [Abstract][Full Text] [Related]
36. Management and outcome of high-grade multicentric gliomas: a contemporary single-institution series and review of the literature.
di Russo P; Perrini P; Pasqualetti F; Meola A; Vannozzi R
Acta Neurochir (Wien); 2013 Dec; 155(12):2245-51. PubMed ID: 24105045
[TBL] [Abstract][Full Text] [Related]
37. Identifying malignant transformations in recurrent low grade gliomas using high resolution magic angle spinning spectroscopy.
Constantin A; Elkhaled A; Jalbert L; Srinivasan R; Cha S; Chang SM; Bajcsy R; Nelson SJ
Artif Intell Med; 2012 May; 55(1):61-70. PubMed ID: 22387185
[TBL] [Abstract][Full Text] [Related]
38. Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.
Liu APY; Hastings C; Wu S; Bass JK; Heitzer AM; Ashford J; Vestal R; Hoehn ME; Ghazwani Y; Acharya S; Conklin HM; Boop F; Merchant TE; Gajjar A; Qaddoumi I
Cancer; 2019 Apr; 125(7):1163-1175. PubMed ID: 30620400
[TBL] [Abstract][Full Text] [Related]
39. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.
Shahar T; Rozovski U; Hess KR; Hossain A; Gumin J; Gao F; Fuller GN; Goodman L; Sulman EP; Lang FF
Neuro Oncol; 2017 May; 19(5):660-668. PubMed ID: 28453745
[TBL] [Abstract][Full Text] [Related]
40. Pattern of recurrence in paediatric malignant glioma: an institutional experience.
Vaidya SJ; Hargrave D; Saran F; Britton J; Soomal R; Bouffet E
J Neurooncol; 2007 Jul; 83(3):279-84. PubMed ID: 17530177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
